To further support the anti-tumor role of AIM2 in HCC, it was recently found that a higher expression of AIM2 was associated with a better prognosis of HCC patients in terms of overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) [30]. The gene discussed is AIM2; the disease is hepatocellular carcinoma.